Purchase Order 75N92025P00055

Award Date 2/28/25
Potential Completion Date 2/27/26
Potential Value Not listed
Awardee
Medviso AB
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Medviso AB, a Swedish medical technology company. The $16,955.00 contract provides Medviso's Segment cardiac magnetic resonance (CMR) analysis software, licenses, and associated maintenance and support to facilitate cardiovascular research data acquisition and processing for NIH and partner...
This is a $16,080 firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Medviso AB, a Swedish medical technology company. The contract is for a 24-month software license and maintenance agreement to provide Segment cardiac magnetic resonance (CMR) analysis packages to support cardiovascular research programs at the NIH Clinical Center and Medstar Washington Hospital Center. The packages...
This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) to Medviso AB, a Swedish medical technology company, for the provision of Segment cardiac magnetic resonance (CMR) analysis software packages and associated maintenance and support services. The $16,920.00 contract is a renewal to ensure the proper functioning of MRI equipment critical for ongoing cardiovascular research programs at the NIH Clinical...
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $63,034 purchase order to Medviso AB. Under the contract, Medviso will provide CMR Analysis Packages site software to support research at the National Heart Lung and Blood Institute and Washington Hospital Center. The firm-fixed price contract runs from January 2021 through February 2022 and will be performed in Sweden. No set aside provisions or subcontractors were...
Medviso AB, a Swedish medical technology company, was awarded a $15,620 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to deliver CMR analysis packages and associated maintenance renewals. The award, which has no set aside designation, supports the agency's request for maintenance of specialized cardiac magnetic resonance imaging software under NIH NHLBI CB CPL REQUEST FOR MAINTENANCE...
This $71,000 firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to DR Marcus Carlsson AB for the technical development of cardiovascular magnetic resonance imaging. The period of performance is January 16, 2025. No set-aside designation was used for this award to the prime contractor, which will support the National Heart, Lung and Blood Institute's research efforts in cardiovascular...
This is a firm fixed price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to DR Marcus Carlsson AB, a for-profit organization based in Vetlanda, Sweden. The $71,000.00 contract is for the technical development of cardiovascular magnetic resonance imaging (MRI) technology to support NHLBI's research efforts in cardiovascular disease. The contract has a period of performance from...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $46,161.66, is for the provision of a Magnetic Resonance Imaging (MRI) technician to support patient services for the NHLBI laboratory. The contract has a period of performance from March 21, 2024 to March 20, 2025 and was...
<p>This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, to Medis Medical Imaging System Inc. for ADP software. The contract has a ceiling value of $150,000 and an ultimate completion date of November 11, 2015. It is a firm fixed-price purchase order for MEDIS medical imaging software for the NHLBI Division of Intramural Research. The contract does not have a set-aside designation.</p>
This federal contract award is for $13,000 and was issued by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Esaote North America Inc., a foreign-owned, for-profit medical technology company, to provide structural heart medical imaging software to support the NHLBI Lederman Laboratory's staffing, workflow, and research priorities. The contract does not have a set-aside designation,...

This is a purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services, to Medviso AB, a Swedish medical technology company. The $16,400 firm-fixed-price contract is for the provision of Segment cardiac magnetic resonance (CMR) analysis software packages, licenses, and associated maintenance services. The contract supports ongoing cardiovascular research programs at the NIH Clinical Center and partner institutions by ensuring proper functioning of quantitative cardiac MRI/CT analysis capabilities. The contract has a period of performance from February 28, 2025 to February 27, 2026 and does not have a set-aside designation.

Generated 1/22/25, 9:29 AM